Pharmaceutical & Medical Supply Chain Monitoring

SART Consult delivers nationwide monitoring of pharmaceutical and medical supply chains—from central warehouses to the last mile—so decision-makers can see what’s available, where gaps exist, and how to act. Our portfolio spans national facility surveys, emergency medical-supply TPM, longitudinal panels, and tracer-item tracking across public and private providers.

Scope of Work

  • National facility surveys of tracer items: Availability, stock management, storage conditions, documentation, and utilization—covering hospitals, health centers, and health posts.
  • Emergency supply TPM: Independent verification from dispatch to use; beneficiary/staff feedback; compliance with donor agreements.
  • Longitudinal panel monitoring: Repeated rounds (in-person + CATI) across 900+ facilities to link market-shaping efforts to on-the-ground availability.
  • Mixed provider coverage: Public facilities and private outlets for program-specific drugs.

Selected Assignments (evidence base)

  • WHO Emergency Medical Supplies TPM (2024): 101 sites across all regions—full chain from dispatch to utilization.
  • IPLS Survey (JSI, 2018): 456 facilities nationwide (56 hospitals, 249 health centers, 151 health posts).
  • Market Shaping Capacity Improvement II (R4D, 2024–2026): Six rounds, 900+ panel facilities (Round 1 in-person; subsequent rounds via CATI).
  • Product Availability Spot-Checks (PwC/LFA to Global Fund, 2019–2022): Biannual checks for TB/HIV/malaria services.
  • Key Medical Supplies TPM (MSI/USAID, 2024): ~40 tracer commodities; includes mystery client visits to private facilities.

How We Work

  • Rigorous methods: Structured interviews (storekeepers/managers), direct observation, register/document reviews, and facility audits—augmented by sector expert field team.
  • Tech-enabled QA: Mobile data capture (ODK/SurveyCTO/SurveyToGo), time/GPS stamps, photo prompts, automated validations, and multi-tier back-checks.
  • Panel & remote operations: Stable facility panels, CATI follow-ups, and standard operating procedures for round-to-round comparability.
  • Governance & compliance: Donor-aligned protocols (WHO, USAID, Global Fund), secure data flows, anonymization, and rapid reporting for action.

Value & Results

  • System visibility: A clear, actionable picture of supply availability, storage practices, and last-mile performance.
  • Actionable signals: Early identification of stock-outs, cold-chain/storage risks, documentation gaps, and delivery bottlenecks—prioritized via tracer items.
  • Adaptive management: Longitudinal evidence links market-shaping and procurement decisions to facility-level availability, enabling course-corrections.
  • Coverage you can trust: Evidence generated across all regions and provider types with sector expert field team under consistent quality controls.